SEC Form 4 · accession 0001650664-26-000068
Editas Medicine, Inc. · EDIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliott M. Levy
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 4:28 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001650664
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.55 | Jun 17, 2026 | A | 51,700 | A | — | Jun 16, 2036 | Common Stock | 51,700 | 51,700 | D |
Explanation of responses
- F1This option was granted on June 17, 2026 and is scheduled to vest in full on June 17, 2027.